Carey Gillam writes:
“The U.S. Environmental Protection Agency (EPA) failed to follow established guidelines for determining cancer risk, ignored important studies, and discounted expert advice from a scientific advisory panel in officially declaring that the weed killer glyphosate was “not likely to be carcinogenic,” a federal court said in an order issued Friday.
The 9th U.S Circuit Court of Appeals said the agency’s 2020 assessment of glyphosate, the active ingredient in Roundup, was flawed in many ways, applying “inconsistent reasoning” in finding that the chemical does not pose “any reasonable risk to man or the environment.”
The court vacated the human health portion of the EPA’s glyphosate assessment and said the agency needed to apply “further consideration” to evidence. The 9th Circuit also said that the EPA was in violation of the Endangered Species Act in its assessment of glyphosate.
The decision comes at a critical time for Monsanto owner Bayer AG. Bayer is seeking to put an end to thousands of lawsuits filed by U.S. Roundup users who developed non-Hodgkin lymphoma and allege their exposure to the weed killer is to blame for their cancers.
Bayer denies there is any cancer connection between glyphosate and Roundup, and has repeatedly cited the EPA’s assurances of glyphosate safety as a key part of its defense. Bayer maintains that the backing of the EPA and similar support from other regulators in other countries is more valid than the 2015 assessment by the World Health Organization’s International Agency for Research on Cancer (IARC), which found that glyphosate was “probably” carcinogenic to humans.”
For a full report on Monsanto’s Roundup (active ingredient glyphosate) go to the internal search engine on the upper right hand side of the OCA homepage and type in the words Monsanto’s Roundup.